Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Maravai LifeSciences Holdings's
Operating Income
for the
three
months ended in Mar. 2026 was MXN13 Mil. Maravai LifeSciences Holdings's Interest Expense for the
three
months ended in Mar. 2026 was MXN-104 Mil.
Maravai LifeSciences Holdings's interest coverage for the quarter that ended in Mar. 2026 was 0.13.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Maravai LifeSciences Holdings's Interest Coverage or its related term are showing as below:
MEX:MRVI's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.07 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Maravai LifeSciences Holdings Interest Coverage Related Terms
Maravai LifeSciences Holdings Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
MEX:MRVI vs LBRX, SLDB, JANX: Interest Coverage Comparison
For the Biotechnology subindustry, Maravai LifeSciences Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maravai LifeSciences Holdings Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Maravai LifeSciences Holdings's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings (MEX:MRVI) has a Interest Coverage of 0.13 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Maravai LifeSciences Holdings and its competitors. This is 96% below median its historical median of 3.28. According to the industry distribution chart, Maravai LifeSciences Holdings ranks #999999 out of 377 companies in the Biotechnology industry.
Is Maravai LifeSciences Holdings' Interest Coverage too high?
Maravai LifeSciences Holdings' current Interest Coverage of 0.13 is 96% below median its 10-year median of 3.28. The Biotechnology industry median Interest Coverage is 106.07. Maravai LifeSciences Holdings' value of 0.13 is 99.9% below this industry median. Based on the distribution chart, Maravai LifeSciences Holdings ranks #999999 out of 377 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Maravai LifeSciences Holdings has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Interest Coverage compare to LBRX and SLDB?
According to the Biotechnology industry distribution chart, Maravai LifeSciences Holdings ranks #999999 out of 377 companies for Interest Coverage. This places Maravai LifeSciences Holdings in the lower half of its industry. The industry median Interest Coverage is 106.07. Maravai LifeSciences Holdings' value of 0.13 is 99.9% below this benchmark. While the company's 10-year median is 3.28 vs. the industry median of 106.07, Maravai LifeSciences Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maravai LifeSciences Holdings's current Interest Coverage of 0.13 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Maravai LifeSciences Holdings and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maravai LifeSciences Holdings's current Interest Coverage is 0.13, which is 96% below median its own 10-year median of 3.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current Interest Coverage of 0.13. The stock's GF Value™ is MXN52.37, compared to a current price of MXN85.00 — trading 62.3% above its estimated fair value. The current Interest Coverage is 0.13, which is 96% below median its 10-year median of 3.28 and 99.9% below the Biotechnology industry median of 106.07. Maravai LifeSciences Holdings' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current Interest Coverage is 0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?
Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued.
The current stock price of MXN85.00 is trading 62.3% above its estimated GF Value™ of MXN52.37.
Key valuation signals for MEX:MRVI:
Interest Coverage: 0.13 (96% below median its 10-year median of 3.28)
GF Value™: MXN52.37 vs. price of MXN85.00 (62.3% above fair value)
Industry Position: 99.9% below the Biotechnology median (#999999 of 377)
No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maravai LifeSciences Holdings Business Description
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
62GF Score
Get the complete analysis for MEX:MRVI
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MRVI has been successfully added to your 
